Preischemic infusion of alpha-human atrial natriuretic peptide elicits myoprotection through a nitric oxide-dependent mechanism

Journal of Cardiology

Volumn 39, Issue 6, 2002, Pages 299-304

  Okawa, Hirohisa ^a   Horimoto, Hitoshi ^a   Mieno, Shigetoshi ^a   Nomura, Yukiya ^a   Nakahara, Kenichi ^a   Yoshida, Masataka ^a   Asada, Kunio ^a   Sasaki, Shinjiro ^a  

^a OSAKA MEDICAL COLLEGE   (Japan)

Author keywords

Ischemia, preconditioning; Ischemia, reperfusion; Myocardial infarction, pathophysiology; Natriuretic peptide, atrial; Nitric oxide

Indexed keywords

ATRIAL NATRIURETIC FACTOR ALPHA; N(G) NITROARGININE METHYL ESTER; NITRIC OXIDE; ATRIAL NATRIURETIC FACTOR;

ANIMAL TISSUE; ARTICLE; CORONARY ARTERY BLOOD FLOW; HEART FAILURE; HEART INFARCTION; HEART INFARCTION PREVENTION; HEART INFARCTION SIZE; HEART LEFT VENTRICLE PRESSURE; HEART PROTECTION; ISOLATED HEART; NONHUMAN; RAT; REPERFUSION INJURY; VASODILATATION; ANIMAL; HEART MUSCLE REPERFUSION; MALE; PATHOPHYSIOLOGY; PHYSIOLOGY; SPRAGUE DAWLEY RAT;

ANIMALS; ATRIAL NATRIURETIC FACTOR; ISCHEMIC PRECONDITIONING, MYOCARDIAL; MALE; MYOCARDIAL INFARCTION; MYOCARDIAL REPERFUSION; NITRIC OXIDE; RATS; RATS, SPRAGUE-DAWLEY;

EID: 0036596812     PISSN: 09145087     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. Maack T, Marion DN, Camargo MJF, Kleinen HD, Laragh JH, Vaughn ED Jr, Atlas SA: Effects of auriculin (atrial natriuretic factor) on blood pressure, renal function, and the renin-aldosterone system in dogs. Am J Med 1984; 77: 1069-1075
2. Weder AB, Sekkarie MA, Takiyyuddin M, Schork NJ, Julius S: Antihypertensive and hypotensive effects of atrial natriuretic factor in men. Hypertension 1987; 10: 582-589
3. Winquist RJ, Faison EP, Nutt RF: Vasodilator profile of synthetic atrial natriuretic factor. Eur J Pharmacol 1984; 102: 169-173
4. Naruse M, Obana K, Naruse K, Yamaguchi H, Demura H, Inagami T, Shizume K: Atrial natriuretic polypeptide inhibits cortisol secretion as well as aldosterone secretion in vitro from human adrenal tissue. J Clin Endocrinol Metab 1987; 64: 10-16
5. Atarashi K, Mulrow PJ, Franco-Saenz R, Snajdar R, Rapp J: Inhibition of aldosterone production by an atrial extract. Science 1984; 224: 992-994
6. Waldman SA, Rapoport RM, Murad F: Atrial natriuretic factor selectively activates paniculate guanylate cyclase and elevates cyclic GMP in rat tissue. J Biol Chem 1984; 259: 14332-14334
7. Soualmia H, Barthelemy C, Eurin J, Masson F, Carayon A: Role of nitric oxide on atrial natriuretic peptide release induced by angiotensin II in superfused rat atrial tissue. Regul Pept 2001; 98: 105-110
8. Waldman SA, Murad F: Biochemical mechanisms underlying vascular smooth muscle relaxation: The guanylate cyclase-cyclic GMP system. J Cardiovasc Pharmacol 1988; 12(Suppl 5): S115-S118
9. Ali IS, Gandhi M, Finegan BA, Koshal A, Clanachan AS: Cardioprotection by activation of NO/cGMP pathway after cardioplegic arrest and 8-hour storage. Ann Thorac Surg 1998; 65: 1303-1309
10. Horimoto H, Gaudette GR, Saltman AE, Krukenkamp IB: The role of nitric oxide, K(+)(ATP)channels, and cGMP in the preconditioning response of the rabbit. J Surg Res 2000; 92: 56-63
11. 2+ channel activity by human natriuretic peptide in rabbit heart cells. Br J Pharmacol 1995; 114: 1076-1082
12. Zhu P, Zaugg CE, Simper D, Hornstein P, Allegrini PR, Buser PT: Bradykinin improves postischaemic recovery in the rat heart: Role of high energy phosphates, nitric oxide, and prostacyclin. Cardiovasc Res 1995; 29: 658-663
13. Valen G, Skjelbakken T, Vaage J: The role of nitric oxide in the cardiac effects of hydrogen peroxide. Mol Cell Biochem 1996; 159: 7-14
14. Balligand JL, Kelly RA, Marsden PA, Smith TW, Michel T: Control of cardiac muscle cell function by an endogenous nitric oxide signaling system. Proc Natl Acad Sci USA 1993; 90: 347-351
15. Levi RC, Alloatti G, Fischmeister R: Cyclic GMP regulates the Ca-channel current in guinea pig ventricular myocytes. Pflugers Arch 1989; 413: 685-687
16. Xie YW, Shen W, Zhao G, Xu X, Wolin MS, Hintze TH: Role of endothelium-derived nitric oxide in the modulation of canine myocardial mitochondrial respiration in vivo: Implications for the development of heart failure. Circ Res 1996; 79: 381-387
17. Liu H, McPherson BC, Zhu X, Da-Costa ML, Jeevanandam V, Yao Z: Role of nitric oxide and protein kinase C in ACh-induced cardioprotection. Am J Physiol Heart Circ Physiol 2001; 281: H191-H197
18. Chinkers M, Garbes DL: Signal transduction by guanylate cyclase. Annu Rev Biochem 1991; 60: 553-575
19. Brady AJB, Warren JB, Poole-Wilson PA, Williams TJ, Harding SE: Nitric oxide attenuates cardiac myocyte contraction. Am J Physiol 1993; 265: H176-H182
20. Weiss HR, Rodriguez E, Tse J, Scholz PM: Effect of increased myocardial cyclic GMP induced by cyclic GMP-phosphodiesterase inhibition on oxygen consumption and supply of rabbit hearts. Clin Exp Pharmacol Physiol 1994; 21: 607-614